NCT02616484: An ongoing trial by Saol Therapeutics Inc
This trial is ongoing. It must report results 8 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT02616484 |
|---|---|
| Title | Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency: |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 14, 2020 |
| Completion date | Aug. 27, 2025 |
| Required reporting date | Aug. 27, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |